About Century Therapeutics
Century Therapeutics is a company based in Philadelphia (United States) founded in 2018.. Century Therapeutics has raised $410 million across 4 funding rounds from investors including Fidelity Investments, Marshall Wace and FUJIFILM Cellular Dynamics. The company has 150 employees as of December 31, 2024. Century Therapeutics has completed 3 acquisitions, including Clade TX, Empirica Therapeutics and empirica. Century Therapeutics offers products and services including iPSC-derived NK Cell Therapies and iPSC-derived T Cell Therapies.
- Headquarter Philadelphia, United States
- Employees 150 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Century Therapeutics, Inc.
-
Annual Revenue
$6.59 M194.81as on Dec 31, 2024
-
Net Profit
$-126.57 M7.4as on Dec 31, 2024
-
EBITDA
$-120.97 M-7.87as on Dec 31, 2024
-
Total Equity Funding
$410 M (USD)
in 4 rounds
-
Latest Funding Round
$135 M (USD), Post-IPO
Jan 08, 2026
-
Investors
Fidelity Investments
& 23 more
-
Employee Count
150
as on Dec 31, 2024
-
Investments & Acquisitions
Clade TX
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Century Therapeutics
Century Therapeutics is a publicly listed company on the NASDAQ with ticker symbol IPSC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Century Therapeutics
Century Therapeutics offers a comprehensive portfolio of products and services, including iPSC-derived NK Cell Therapies and iPSC-derived T Cell Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineered cells for cancer treatment through immune response.
Therapies targeting autoimmune diseases via cellular engineering.
Unlock access to complete
Unlock access to complete
Funding Insights of Century Therapeutics
Century Therapeutics has successfully raised a total of $410M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $135 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $135.0M
-
First Round
First Round
(01 Jul 2019)
- Investors Count 24
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Post-IPO - Century Therapeutics | Valuation | TCG Crossover | |
| Apr, 2024 | Amount | Post-IPO - Century Therapeutics | Valuation |
investors |
|
| Mar, 2021 | Amount | Series C - Century Therapeutics | Valuation | Casdin Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Century Therapeutics
Century Therapeutics has secured backing from 24 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, Marshall Wace and FUJIFILM Cellular Dynamics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Founded Year | Domain | Location | |
|
Investments in healthcare startups are managed by Octagon Capital Advisors.
|
Founded Year | Domain | Location | |
|
Investment firm focused on global life sciences and healthcare.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Century Therapeutics
Century Therapeutics has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Clade TX, Empirica Therapeutics and empirica. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Stem cell-derived therapies for cancer are developed using pluripotent cells.
|
2020 | ||||
|
T-cell therapeutics are developed for brain cancer treatment.
|
2018 | ||||
|
Research and consulting services are provided by empirica.
|
1988 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Century Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Century Therapeutics Comparisons
Competitors of Century Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Century Therapeutics
Frequently Asked Questions about Century Therapeutics
When was Century Therapeutics founded?
Century Therapeutics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Century Therapeutics located?
Century Therapeutics is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Century Therapeutics a funded company?
Century Therapeutics is a funded company, having raised a total of $410M across 4 funding rounds to date. The company's 1st funding round was a Series C of $160M, raised on Jul 01, 2019.
How many employees does Century Therapeutics have?
As of Dec 31, 2024, the latest employee count at Century Therapeutics is 150.
What is the annual revenue of Century Therapeutics?
Annual revenue of Century Therapeutics is $6.59M as on Dec 31, 2024.
What does Century Therapeutics do?
Century Therapeutics was founded in 2018 and is headquartered in Philadelphia, United States. Operations focus on the biotechnology sector, where adult stem cells are harnessed to create therapies targeting cancer. Novel allogeneic living drugs for oncology are being developed to address shortcomings in first-generation cell therapies. The companys efforts center on advancing these cellular treatments through research and development processes.
What products or services does Century Therapeutics offer?
Century Therapeutics offers iPSC-derived NK Cell Therapies and iPSC-derived T Cell Therapies.
Is Century Therapeutics publicly traded?
Yes, Century Therapeutics is publicly traded on NASDAQ under the ticker symbol IPSC.
How many acquisitions has Century Therapeutics made?
Century Therapeutics has made 3 acquisitions, including Clade TX, Empirica Therapeutics, and empirica.
Who are Century Therapeutics's investors?
Century Therapeutics has 24 investors. Key investors include Fidelity Investments, Marshall Wace, FUJIFILM Cellular Dynamics, Orbimed, and RA Capital.
What is Century Therapeutics's ticker symbol?
The ticker symbol of Century Therapeutics is IPSC on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.